GlaxoSmithKline Inc
Registered Principal Details
Business Or Interest:
Pharmaceutical Manufacturer.
Lobbying Interests:
Lobby areas of healthcare, wellness, and pharmaceutical issues.
CEO Name:
Andrew Witty
Director, State Government Affairs
Pharmaceutical Manufacturer.
Lobbying Interests:
Lobby areas of healthcare, wellness, and pharmaceutical issues.
CEO Name:
Andrew Witty
Director, State Government Affairs
Contact
SB
Sandie Benen
47 W. Division Street, #234
Chicago, IL 60610
(312) 504-4080
(312) 335-9821
sandra.e.benen@gsk.com
http://www.gsk.com
47 W. Division Street, #234
Chicago, IL 60610
(312) 504-4080
(312) 335-9821
sandra.e.benen@gsk.com
http://www.gsk.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Sandie Benen | Exclusive Duties N/A | Authorized On 1/21/2011 | Withdrawn On N/A |
| Peter Kammer | Exclusive Duties N/A | Authorized On 2/23/2011 | Withdrawn On N/A |
| Heather Berlinski | Exclusive Duties N/A | Authorized On 2/23/2011 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 151
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
6/3/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
For
Notification Date6/3/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 101
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
6/3/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
For
Notification Date6/3/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 373
Relating to: changes to product liability law and the law governing remedies against manufacturers, distributors, sellers, and promoters of a product.
Bill Text and History
1/12/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: changes to product liability law and the law governing remedies against manufacturers, distributors, sellers, and promoters of a product.
Bill Text and History
None
Notification Date1/12/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
September 2011 Special Session Assembly Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
10/21/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
For
Notification Date10/21/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs
Health Services: Medical Assistance and Related Programs
Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Medicaid reimbursement
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Medicaid reimbursement
Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Drug substitution
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Drug substitution
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Health care reform including health insurance exchanges
Health care reform including health insurance exchanges
Action Intended To Affect
Legislative matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Health care reform including health insurance exchanges.
Health care reform including health insurance exchanges.
Action Intended To Affect
Legislative Matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Transparency in private attorney contracting
Transparency in private attorney contracting
Action Intended To Affect
Legislative Matter
Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Transparency in private attorney action.
Transparency in private attorney action.
Action Intended To Affect
Legislative Matter
Notification Date
3/5/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
3/5/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Relating to the out of pocket cost for orally administered anitcancer medication.
Relating to the out of pocket cost for orally administered anitcancer medication.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.
Development, drafting or introduction of a proposal relating to
Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.
Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2011 January - June $15,792.00 |
2011 July - December $23,448.75 |
2012 January - June $18,836.25 |
2012 July - December $11,216.00 |
Total $69,293.00 |
| Total Hours Communicating | 2011 January - June 20.75 |
2011 July - December 56.25 |
2012 January - June 21.25 |
2012 July - December 8.75 |
Total 107.00 |
| Total Hours Other | 2011 January - June 61.50 |
2011 July - December 113.40 |
2012 January - June 70.50 |
2012 July - December 42.50 |
Total 287.90 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 20% |
2011 July - December 45% |
2012 January - June 60% |
2012 July - December |
Total 37% |
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 40% |
2011 July - December 30% |
2012 January - June 20% |
2012 July - December |
Total 26% |
Relating to: changes to product liability law and the law governing remedies against manufacturers, distributors, sellers, and promoters of a product.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 5% |
2012 January - June |
2012 July - December |
Total 2% |
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 10% |
2012 January - June |
2012 July - December |
Total 4% |
Budget Bill Subjects
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 10% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 2% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 15% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 3% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 15% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 3% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June 10% |
2012 July - December 80% |
Total 13% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December 10% |
Total 1% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.